NO328208B1 - Inhibitorer for cruzipain og andre cysteinproteaser, fremgangsmate for validering av en kjent eller antatt cysteinproteaseinhibitor som et terapeutisk mal, anvendelser av forbindelsene i fremgangsmaten og ved fremstilling av medikamenter, samt farmasoytiske eller veterinaermedisinske preparater og fremgangsmate for fremstilling derav - Google Patents

Inhibitorer for cruzipain og andre cysteinproteaser, fremgangsmate for validering av en kjent eller antatt cysteinproteaseinhibitor som et terapeutisk mal, anvendelser av forbindelsene i fremgangsmaten og ved fremstilling av medikamenter, samt farmasoytiske eller veterinaermedisinske preparater og fremgangsmate for fremstilling derav Download PDF

Info

Publication number
NO328208B1
NO328208B1 NO20033220A NO20033220A NO328208B1 NO 328208 B1 NO328208 B1 NO 328208B1 NO 20033220 A NO20033220 A NO 20033220A NO 20033220 A NO20033220 A NO 20033220A NO 328208 B1 NO328208 B1 NO 328208B1
Authority
NO
Norway
Prior art keywords
oxohexahydrofuro
oxo
pyrrol
ethyl
alkyl
Prior art date
Application number
NO20033220A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033220L (no
NO20033220D0 (no
Inventor
Martin Quibell
Original Assignee
Amura Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0101179A external-priority patent/GB0101179D0/en
Application filed by Amura Therapeutics Ltd filed Critical Amura Therapeutics Ltd
Publication of NO20033220D0 publication Critical patent/NO20033220D0/no
Publication of NO20033220L publication Critical patent/NO20033220L/no
Publication of NO328208B1 publication Critical patent/NO328208B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20033220A 2001-01-17 2003-07-16 Inhibitorer for cruzipain og andre cysteinproteaser, fremgangsmate for validering av en kjent eller antatt cysteinproteaseinhibitor som et terapeutisk mal, anvendelser av forbindelsene i fremgangsmaten og ved fremstilling av medikamenter, samt farmasoytiske eller veterinaermedisinske preparater og fremgangsmate for fremstilling derav NO328208B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0101179A GB0101179D0 (en) 2001-01-17 2001-01-17 Biologically active compounds
US27535901P 2001-03-13 2001-03-13
PCT/GB2002/000184 WO2002057270A1 (fr) 2001-01-17 2002-01-17 Inhibiteurs de la cruzipaine et autres cysteines proteases

Publications (3)

Publication Number Publication Date
NO20033220D0 NO20033220D0 (no) 2003-07-16
NO20033220L NO20033220L (no) 2003-09-17
NO328208B1 true NO328208B1 (no) 2010-01-11

Family

ID=26245571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033220A NO328208B1 (no) 2001-01-17 2003-07-16 Inhibitorer for cruzipain og andre cysteinproteaser, fremgangsmate for validering av en kjent eller antatt cysteinproteaseinhibitor som et terapeutisk mal, anvendelser av forbindelsene i fremgangsmaten og ved fremstilling av medikamenter, samt farmasoytiske eller veterinaermedisinske preparater og fremgangsmate for fremstilling derav

Country Status (21)

Country Link
US (2) US7425562B2 (fr)
EP (1) EP1362052B1 (fr)
JP (1) JP4608183B2 (fr)
KR (1) KR100860067B1 (fr)
CN (1) CN1269822C (fr)
AT (1) ATE356130T1 (fr)
AU (1) AU2002219397B2 (fr)
BR (1) BR0206501A (fr)
CA (1) CA2436462C (fr)
CY (1) CY1106640T1 (fr)
DE (1) DE60218633T2 (fr)
DK (1) DK1362052T3 (fr)
ES (1) ES2281516T3 (fr)
HK (1) HK1060729A1 (fr)
IL (2) IL156774A0 (fr)
MX (1) MXPA03006224A (fr)
NO (1) NO328208B1 (fr)
NZ (1) NZ526913A (fr)
PT (1) PT1362052E (fr)
RU (1) RU2329266C2 (fr)
WO (1) WO2002057270A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
JP2004523506A (ja) 2000-12-22 2004-08-05 アクシス・ファーマシューティカルズ・インコーポレイテッド カテプシン阻害剤としての新規な化合物と組成物
MXPA04002282A (es) 2001-09-14 2005-03-07 Axis Pharmaceutical Inc Nuevos compuestos y preparaciones como inhibidores de la catepsina.
RU2004117877A (ru) 2001-11-14 2006-01-10 Авентис Фармасьютикалз Инк. (Us) Олигопептиды и композиции, содержащие их, в качестве ингибиторов катепсина s
BR0312662A (pt) * 2002-07-16 2005-05-03 Amura Therapeutics Ltd Compostos biologicamente ativos
US7399765B2 (en) * 2003-09-19 2008-07-15 Abbott Laboratories Substituted diazabicycloalkane derivatives
WO2005066180A1 (fr) 2004-01-08 2005-07-21 Medivir Ab Inhibiteurs de cysteine protease
JP2005350417A (ja) * 2004-06-11 2005-12-22 Dai Ichi Seiyaku Co Ltd 還元的エーテル化法を用いたピロリジン誘導体の製造法
EA017874B1 (ru) * 2005-03-21 2013-03-29 Вайробей, Инк. Производные альфа-кетоамидов в качестве ингибиторов цистеинпротеаз
GB0513840D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0513839D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0614053D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614052D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614044D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614042D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614037D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614046D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614073D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
WO2008114054A1 (fr) * 2007-03-19 2008-09-25 Medivir Ab Inhibiteurs de protéase
US7893067B2 (en) * 2007-06-27 2011-02-22 Medivir Ab Cysteine protease inhibitors
WO2009087379A2 (fr) * 2008-01-09 2009-07-16 Amura Therapeutics Limited Composés
GB0804701D0 (en) * 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
GB0804702D0 (en) * 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
WO2012099785A2 (fr) * 2011-01-20 2012-07-26 The Regents Of The University Of Colorado, A Body Corporate Modulateurs du complexe tlr3/arnds et leurs utilisations
JP6218734B2 (ja) 2012-08-30 2017-10-25 国立大学法人 東京大学 内部寄生虫防除剤
CN106279188A (zh) * 2016-07-21 2017-01-04 青岛科技大学 一种多取代呋喃并[2,3‑b]吡咯衍生物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652574A (en) * 1970-04-01 1972-03-28 Abbott Lab Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof
DZ2285A1 (fr) 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
WO1998008802A1 (fr) 1996-08-28 1998-03-05 Smithkline Beecham Corporation Inhibiteurs de cysteine protease
EA002100B1 (ru) 1996-12-23 2001-12-24 Элан Фармасьютикалз, Инк. ЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ, ЛАКТАМЫ, ЛАКТОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЫСВОБОЖДЕНИЯ И/ИЛИ СИНТЕЗА β-АМИЛОИДНОГО ПЕПТИДА С ПОМОЩЬЮ УКАЗАННЫХ СОЕДИНЕНИЙ
AR013079A1 (es) 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
CO5150165A1 (es) 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
GB9911417D0 (en) * 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s
IL155961A0 (en) 2000-11-17 2003-12-23 Medivir Uk Ltd Cysteine protease inhibitors
JP2004523506A (ja) 2000-12-22 2004-08-05 アクシス・ファーマシューティカルズ・インコーポレイテッド カテプシン阻害剤としての新規な化合物と組成物

Also Published As

Publication number Publication date
CN1269822C (zh) 2006-08-16
AU2002219397B2 (en) 2008-02-14
RU2003125270A (ru) 2005-02-20
CY1106640T1 (el) 2012-01-25
EP1362052B1 (fr) 2007-03-07
WO2002057270A1 (fr) 2002-07-25
DE60218633T2 (de) 2008-02-21
DK1362052T3 (da) 2007-07-09
US7425562B2 (en) 2008-09-16
KR100860067B1 (ko) 2008-09-24
DE60218633D1 (de) 2007-04-19
CA2436462A1 (fr) 2002-07-25
ATE356130T1 (de) 2007-03-15
NO20033220L (no) 2003-09-17
CA2436462C (fr) 2011-07-05
HK1060729A1 (en) 2004-08-20
RU2329266C2 (ru) 2008-07-20
PT1362052E (pt) 2007-04-30
NZ526913A (en) 2004-12-24
JP2004518674A (ja) 2004-06-24
JP4608183B2 (ja) 2011-01-05
NO20033220D0 (no) 2003-07-16
US20090247471A1 (en) 2009-10-01
MXPA03006224A (es) 2004-10-15
ES2281516T3 (es) 2007-10-01
IL156774A0 (en) 2004-02-08
CN1486320A (zh) 2004-03-31
EP1362052A1 (fr) 2003-11-19
KR20030075161A (ko) 2003-09-22
US20040138250A1 (en) 2004-07-15
IL156774A (en) 2008-08-07
BR0206501A (pt) 2004-01-13

Similar Documents

Publication Publication Date Title
NO328208B1 (no) Inhibitorer for cruzipain og andre cysteinproteaser, fremgangsmate for validering av en kjent eller antatt cysteinproteaseinhibitor som et terapeutisk mal, anvendelser av forbindelsene i fremgangsmaten og ved fremstilling av medikamenter, samt farmasoytiske eller veterinaermedisinske preparater og fremgangsmate for fremstilling derav
AU2002219397A1 (en) Inhibitors of cruzipain and other cysteine proteases
JP2006504651A (ja) 生物活性化合物
JP5343011B2 (ja) C型肝炎の治療のための化合物
JP2011518120A (ja) 化合物
DK2646443T3 (en) CAT-II inhibitors
Beyer et al. Asymmetric total synthesis of the indole alkaloid cyclopiazonic acid and first structure–activity data
US6958358B2 (en) Inhibitors of cruzipain and other cysteine proteases
EP1362042A1 (fr) 2-carbonylaminocetones cycliques, inhibiteurs de la cruzipain et autres cysteine proteases
US7132449B2 (en) Inhibitors of cruzipain and other cysteine proteases
WO2007023281A2 (fr) Composes biologiquement actifs
US20040127549A1 (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
US7846934B2 (en) Furo[3,2-B] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
AU2006277710A1 (en) Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles
AU2002225157A1 (en) Inhibitors of cruzipain and other cysteine proteases
BRPI0206501B1 (pt) An inhibitor compound of cruzipain and other cysteine ​​proteases, their uses, their pharmaceutical or veterinary composition, the process for the preparation of said composition and the method of establishing whether a cysteine ​​protease contributes to a biochemical function
AU2002219399A1 (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
Haller Suberone-based type I½ p38α MAPK-inhibitors with improved properties to treat colorectal cancer
KR20050019877A (ko) 생물학적으로 활성이 있는 화합물
UA80250C2 (en) Inhibitors of cruzipain and other cysteine proteases

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees